Metraipolis › archive › dc_e1dadef4bbbd

Enzyme replacement therapy in infants and very young children with Gaucher disease using velaglucerase alfa: a single-center experience — Europe PMC PMID:41181181

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41181181
DOI: 10.3389/fped.2025.1613599
License (as archived): solo-consultazione
Archived: 2026-11-09T06:14:59.464Z
SHA-256 of the archived text: 4691b69130af0e80d165055f6d7055840677cf9329fafff9de79ca5b184f1566
Stable URL of this page: https://metraipolis.com/documento/dc_e1dadef4bbbd

How to cite

Enzyme replacement therapy in infants and very young children with Gaucher disease using velaglucerase alfa: a single-center experience — Europe PMC PMID:41181181 — Europe PMC (en), https://europepmc.org/article/MED/41181181 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e1dadef4bbbd (Metraipolis archive dc_e1dadef4bbbd, sha256 4691b69130af0e80d165055f6d7055840677cf9329fafff9de79ca5b184f1566)

BibTeX

@misc{dce1dadef4bbbd,
  title = {Enzyme replacement therapy in infants and very young children with Gaucher disease using velaglucerase alfa: a single-center experience — Europe PMC PMID:41181181},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41181181},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e1dadef4bbbd; sha256 4691b69130af0e80d165055f6d7055840677cf9329fafff9de79ca5b184f1566},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41181181. Agents can read the archived copy with the MCP tool read_document.